key: cord-0998323-9i4ug4d2
authors: Banerjee, Niladri; Banerjee, Anannya Ray; Agarwal, Harshita; Agarwal, Harshit
title: An epidemic within a pandemic
date: 2022-01-03
journal: Trop Doct
DOI: 10.1177/00494755211041876
sha: 7d2a15873fb4866f4118a35740b64ee85be50e58
doc_id: 998323
cord_uid: 9i4ug4d2

nan

such as tocilizumab also increases the risk of infection. Mucormycosis can affect the lungs, intestines, open wounds in the extremities, the face or the brain. The surge in India is, however, predominantly of rhinoorbito-cerebral mucormycosis (ROCM), whose spectrum ranges from small lesions to destruction of the eyeball and cavernous sinus thrombosis. It has been suggested that this increased incidence of ROCM may be due to increased requirements of oxygen supplementation in patients with COVID-19, thus leading to a drying out of the nasopharyngeal mucosa. Diabetes mellitus is found in 62.3% of ROCM cases in India. 3 Corticosteroids, of course, act as immunosuppressants but also lead to deranged glucose tolerance, thus doubly contributing to mucormycosis. Furthermore, recent evidence is that COVID-19 can itself destroy b-cells of the pancreas, leading to new-onset hyperglycaemia. 4 The successful management of ROCM depends upon its early identification in patients with risk factors, and initiation of prompt effective treatment which may mean a multidisciplinary team approach. Simple tests for vision, pupil and ocular motility and examination for sinus tenderness, proptosis, palpebral oedema and palatal eschars, should become part of routine physical evaluation of all COVID-19 patients hospitalised with moderate to severe infection (especially those taking systemic corticosteroids, diabetics and those on prolonged oxygen support). In the initial stages, there may be features of cellulitis or oedema with blackening of tissues, later owing to cell death. Features such as diplopia, visual loss, headache, convulsions, altered mental status, cranial nerve palsy or gait disturbances suggest cerebral involvement.

A nasal swab for potassium hydroxide mount and culture is necessary. Treatment involves the use of liposomal amphotericin B and/or posaconazole together with endoscopic or open sinus debridement. The mortality rate of ROCM remains high (50% even in hospitalised patients), 5 particularly in the elderly, where there is cerebral involvement, and in patients already admitted to intensive care units. 6 Since fungal infections develop during the middle and later stages of COVID-19 infection, follow-up of high-risk patients recovering from this infection is also important. Immediate attention is called for if periocular swelling, double vision, unilateral facial or orbital pain or headache ensue.

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Harshit Agarwal https://orcid.org/0000-0002-6658-9626

COVID-19 and orbital mucormycosis

Opportunistic fungal infections in the epidemic area of COVID-19: a clinical and diagnostic perspective from Iran

Viral infiltration of pancreatic islets in patients with COVID-19

Clinical features and outcome of mucormycosis

Multicenter epidemiologic study of coronavirus disease-associated Mucormycosis